Literature DB >> 35070921

A Prospective Longitudinal Study to Evaluate the Outcomes of Success of Endoscopic DCR in Pediatric Age Group.

Renu Poonia1, Yogesh Aseri1, Digvijay Singh Rawat1, B K Singh1.   

Abstract

Children with nasolacrimal duct obstruction (NLDO) have different therapeutic approach from that used in adults. Dacryocystorhinostomy (DCR) is the most common procedure in adults but it is less frequently carried out in children, indicated in children which are refractory to probing. The objective of the study is to report a series of 30 cases of paediatric epiphora who underwent endoscopic endonasal dacryocystorhinostomy surgery, for primary obstruction of nasolacrimal duct and results, outcomes of success are evaluated. This is a prospective and non-comparative review of 30 cases of epiphora aged between 3 and 9 years from April 2018 to March 2019. The main outcome measures assessed were determined by the resolution of symptoms and the patency of the lacrimal anatomy confirmed by syringing or irrigating the nasolacrimal duct. Secondary outcomes included the presence of such complications as bleeding, scarring, and/or persistent epiphora and infection. In our study 30 patients underwent unilateral DCR surgery in NLDO. Out of 30 patients males were 17 and females were 13. The overall success rate of endoscopic DCR was 90%, and failed cases were mainly due to pre-saccal obstruction. No major complications were reported, minor complications occurred in about 60% of cases. Analysis of the results indicated that EDCR was safe and an effective therapeutic approach for treating nasolacrimal duct obstruction in pediatric age group patients having NLDO. It's considered as an alternative procedure to external dacryocystorhinostomy after a failed conservative treatment. © Association of Otolaryngologists of India 2020.

Entities:  

Keywords:  Dacryocystitis; Endoscopic DCR (EDCR); Naso lacrimal duct obstruction; Pediatrics

Year:  2020        PMID: 35070921      PMCID: PMC8743305          DOI: 10.1007/s12070-020-02109-z

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  15 in total

1.  Primary endoscopic dacryocystorhinostomy in children -- analysis of 18 patients.

Authors:  Ashok K Gupta; Sandeep Bansal
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-01-24       Impact factor: 1.675

2.  Epiphora during the first year of life.

Authors:  C J MacEwen; J D Young
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

3.  Endoscopic transnasal dacryocystorhinostomy.

Authors:  M McDonogh; J H Meiring
Journal:  J Laryngol Otol       Date:  1989-06       Impact factor: 1.469

4.  Primary pediatric endonasal dacryocystorhinostomy--a review of 58 procedures.

Authors:  Pavel Komínek; Stanislav Cervenka; Petr Matousek; Tomás Pniak; Karol Zeleník
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-04-03       Impact factor: 1.675

5.  Endoscopic dacryocystorhinostomy in children.

Authors:  D K Vanderveen; D T Jones; H Tan; R A Petersen
Journal:  J AAPOS       Date:  2001-06       Impact factor: 1.220

6.  Endonasal dacryocystorhinostomy in children: Our experience.

Authors:  Hetal Marfatia; Keya Shah; Swapna Patil; Yogesh Parmar
Journal:  Int J Surg       Date:  2017-09-28       Impact factor: 6.071

7.  Pediatric endonasal dacryocystorhinostomy: a report of 34 cases.

Authors:  Pavel Komínek; Stanislav Cervenka
Journal:  Laryngoscope       Date:  2005-10       Impact factor: 3.325

8.  Endonasal endoscopic dacryocystorhinostomy in children.

Authors:  M J Cunningham; J J Woog
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-03

9.  Pediatric endonasal endoscopic dacryocystorhinostomy.

Authors:  Ph Eloy; E Leruth; A Cailliau; S Collet; B Bertrand; Ph Rombaux
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-04-19       Impact factor: 1.675

10.  Prospective randomized comparison of endonasal endoscopic dacryocystorhinostomy and external dacryocystorhinostomy.

Authors:  J Hartikainen; J Antila; M Varpula; P Puukka; H Seppä; R Grénman
Journal:  Laryngoscope       Date:  1998-12       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.